Anyone have any ideas on this? Scuba do you know....
Thanks
Posted 29 June 2017 - 11:56 AM
Anyone have any ideas on this? Scuba do you know....
Thanks
Posted 29 June 2017 - 01:14 PM
In general, pleural effusion occurrence is greatly reduced on lowered dose Sprycel. Dose interruption and/or dose reduction is the preferred treatment plan for patients who have experienced PE. Here is a related study:
What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia
from the article, "In selected intolerant patients, low-dose dasatinib therapy may be a safe and effective alternative treatment option before a treatment discontinuation or change considered"
Note Table 1 ...
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"
Posted 29 June 2017 - 01:22 PM
Scuba, thanks
Posted 30 June 2017 - 02:07 PM
Posted 30 June 2017 - 03:25 PM
My onc would be open to 20 mg daily if she saw more research. 2 patients (3 with Scuba) aren't very convincing. She would rather I stay on 50 mg and stop altogether when I reach 3 years of MMR.
Have her reach out to Dr. Cortes at M.D. Anderson for data.
Diagnosed 11 May 2011 (100% FiSH, 155% PCR)
with b2a2 BCR-ABL fusion transcript coding for the 210kDa BCR-ABL protein
Sprycel: 20 mg per day - taken at lights out with Quercetin and/or Magnesium Taurate
6-8 grams Curcumin C3 complex.
2015 PCR: < 0.01% (M.D. Anderson scale)
2016 PCR: < 0.01% (M.D. Anderson scale)
March 2017 PCR: 0.01% (M.D. Anderson scale)
June 2017 PCR: "undetected"
September 2017 PCR: "undetected"
Posted 01 July 2017 - 07:42 AM
Anyone have any ideas on this? Scuba do you know....
Thanks
I've been on 50 mg since May 2012 due to a PE. I know of 1 or 2 people on this board who continued to have PE issues at half dose. Most of us do fine. Statistically, the majority of people on 100 mg don't experience PE.
Pat
"You can't change the direction of the wind but you can adjust your sails."
DX 12/08; Gleevec 400mg; liver toxicity; Sprycel 100mg.; CCyR 4/10; MMR 8/10; Pleural Effusion 2/12; Sprycel 50mg. Maintaining MMR; 2/15 PCRU; 8/16 drifting in and out of undetected like a wave meeting the shore. Retired 12/23/2016! 18 months of PCRU, most recent at Mayo on 7/25/17 was negative at their new sensitivity reporting of 0.003.<p>
Posted 01 July 2017 - 12:02 PM
Good answer, thanks Pat.
Posted 03 July 2017 - 04:37 PM
Very interesting review. Here's what I can take to my onc: the puny half-life of dasatinib may be a plus in that exposure to subtherapeutic levels of drug is limited, hence not causing resistance to develop.
Dx July 2009 on routine physical. WBC 94. Started Gleevec 400 mg Sept 2009. MMR at 2yrs. Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved. Kidney issues developed because of Gleevec. Switched to Sprycel 70 mg in Aug 2011. Above side effects disappeared or improved. Have been MR3.5 - 4.5 ever since. Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017. After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS. Pleural effusion returned within a couple of months, same as before (moderate, left side only). Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved. At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.
0 members, 1 guests, 0 anonymous users